Business Description
Quantum BioPharma Ltd. is a Canadian biopharmaceutical company based in Toronto that develops treatments for conditions such as multiple sclerosis, depression, inflammatory diseases, and alcohol misuse. Its most advanced drug candidate, Lucid-MS, is currently in Phase 2 clinical trials targeting the root cause of multiple sclerosis, while several other compounds are at earlier stages of development. The company also holds a portfolio of residential property-backed loans as part of its investment activities. Formerly known as FSD Pharma Inc., the company adopted its current name in August 2024.
